Vascular effects of resveratrol

Phytochemicals: Mechanisms of Action

Volumn , Issue , 2003, Pages 145-161

  Wu, Joseph M ^a   Lu, Xiaohua ^a   Guo, Junqiao ^a   Hsieh, Tze Chen ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85056494242     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (60)

1. Gutstein, W.H., Vasospasm, vascular injury, and atherogenesis: A perspective, Hum. Pathol, 30, 365, 1999.
2. Libby, P, Geng, Y.J., Sukhova, G.K., Simon, D.I., and Lee, R.T., Molecular determinants of atherosclerotic plaque vulnerability, Ann. N.Y. Acad. Sci., 811, 134, 1997.
3. Rimm, E.B., Ascherio, A., Giovannucci, E., Spiegelman, D., Stampfer, M.J., and Willett, W.C., Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men, JAMA, 275, 447, 1996.
4. Wolk, A., Manson, J.E., Stampfer, M.J., Colditz, G.A., Hu, F.B., Speizer, F.E., Hen-nekens, C.H., and Willett, W.C., Long-term intake of dietary fiber and decreased risk of coronary heart disease among women, JAMA, 281, 1998, 1999.
5. Joshipura, K.J., Hu, F.B., Manson, J.E., Stampfer, M.J., Rimm, E.B., Speizer, F.E., Colditz, G., Ascherio, A., Rosner, B., Spiegelman, D., and Willett, W.C., The effect of fruit and vegetable intake on risk for coronary heart disease, Ann. Intern. Med., 134, 1106, 2001.
6. Renaud, S. and de Lorgeril, M., Wine, alcohol, platelets, and the French paradox for coronary heart disease, Lancet, 339,1523, 1992.
7. Klatsky, A.L., Armstrong, M.A., and Friedman, G.D., Alcohol and mortality, Ann. Intern. Med., 117, 646, 1992.
8. Seigneur, M., Bonnet, J., Dorian, B., Benchimol, D., Drouillet, D., Gouverneur, G., Larrue, J., Crockett, R., Boiseau, M., Gayon, R., and Bricaus, H., Effect of the consumption of alcohol, white wine, and red wine on platelet function and serum lipids, J. Appl. Cardiol., 5, 215, 1990.
9. Demrow, H.S., Slane, B.S., and Folts, J.D., Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries, Circulation, 91, 1182, 1995.
10. Klurfeld, D.M. and Kritchevsky, D., Differential effects of alcoholic beverages on experimental atherosclerosis in rabbits, Exp. Mol. Pathol., 34, 62, 1981.
11. Wu, J.M., Wang, Z.R., Hsieh, T.C., Bruder, J.L., Zou, J.G., and Huang, Y.Z., Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine, Int. J. Mol. Med., 8, 3, 2001.
12. Burns, J., Crozier, A., and Lean, M.E., Alcohol consumption and mortality: is wine different from other alcoholic beverages?, Nutr. Metab. Cardiovasc. Dis., 11, 249, 2001.
13. Ruf, J.C., Wine and polyphenols related to platelet aggregation and atherothrombosis, Drugs Exp. Clin. Res., 25, 125, 1999.
14. Klatsky, A.L., Armstrong, M.A., and Friedman, G.D., Risk of cardiovascular mortality in alcohol drinkers, ex-drinkers and nondrinkers, Am. J. Cardiol., 66, 1237, 1990.
15. Jackson, R., Scragg, R., and Beaglehole, R., Alcohol consumption and risk of coronary heart disease, Br. Med. J., 303, 211, 1991.
16. Siscovick, D.S., Weiss, N.S., and Fox, N., Moderate alcohol consumption and primary cardiac arrest, Am. J. Epidemiol., 123, 499, 1986.
17. Waterhouse, A.L., Wine phenolics, Ann. N. Y. Acad. Sci., 957, 21, 2002.
18. Siemann, E.H. and Creasy, L.L., Concentration of the phytoalexin resveratrol in wine, Am. J. Enol. Vitic., 43, 49, 1992.
19. Zou, J.G., Huang, Y.Z., Chen, Q., Wei, E.H., Hsieh, T.C., and Wu, J.M., Resveratrol inhibits copper ion-induced and azo compound-initiated oxidative modification of human low-density lipoprotein, Biochem. Mol. Int., 47, 1089, 1999.
20. Zou, J., Huang, Y., Chen, Q., Wei, E., Cao, K., and Wu, J.M., Effects of resveratrol on oxidative modification of human low density lipoprotein, Chin. Med. J., 113, 99, 2000.
21. Schneider, W.J., Goldstein, J.L., and Brown, M.S., Purification of the LDL receptor, Methods Enzymol., 109, 405, 1985.
22. Kroll, M.H., Hellums, J.D., McIntire, L.V., Schafer, A.I., and Moake, J.L., Platelets and shear stress, Blood, 88, 1525, 1996.
23. Kirk, R.I., Deitch, J.A., Wu, J.M., and Lerea, K.M., Resveratrol decreases early signalling events in washed platelets but has little effect on platelet aggregation in whole blood, Blood Cells Mol. Dis., 26, 144, 2000.
24. Wang, Z., Huang, Y., Zou, J., Cao, K., Xu, Y., and Wu, J.M., Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro, Int. J. Mol. Med., 9, 77, 2002.
25. Wang, Z., Zou, J., Huang, Y., Cao, K., Xu, K., and Wu, J.M., Effect of resveratrol on platelet aggregation in vivo and in vitro. Chin. Med. J., 115, 378, 2002.
26. Landolfi, R., Mower, R.L., and Steiner, M., Modification of platelet function and arachidonic acid metabolism by bioflavonoids. Structure-activity relations, Biochem. Pharmacol., 33, 1525, 1984.
27. Corvazier, E. and Maclouf, J., Interference of some flavonoids and non-steroidal antiinflammatory drugs with oxidative metabolism of arachidonic acid by human platelets and neutrophils, Biochim. Biophys. Acta., 835, 315, 1985.
28. Mower, R.L., Landolfi, R., and Steiner, M., Inhibition in vitro of platelet aggregation and arachidonic acid metabolism by flavone, Biochem. Pharmacol., 33, 357, 1984.
29. Gryglewski, R.J., Korbut, R., Robak, J., and Swies, J., On the mechanism of antithrombotic action of flavonoids, Biochem. Pharmacol., 36, 317, 1987.
30. Rotondo, S., Rajtar, G., Manarini, S., Celardo, A., Rotillo, D., de Gaetano, G., Evangelista, V., and Cerletti, C., Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function, Br. J. Pharmacol., 123, 1691, 1998.
31. Zou, J., Huang, Y., Chen, Q., Wang, N., Cao, K., Hsieh, T.C., and Wu, J.M., Suppression of mitogenesis and regulation of cell cycle traverse by resveratrol in cultured smooth muscle cells, Int. J. Oncol., 15, 647, 1999.
32. 2, Cancer Res., 59, 2596, 1999.
33. Bruder, J.L., Hsieh, T.C., Lerea, K.M., Olson, S.C., and Wu, J.M., Cell biological and biochemical analysis of induced cytoskeletal changes in bovine artery endothelial cells by resveratrol and the accompanying modified responses to arterial shear stress, BMC Cell Biol., 2, 1, 2001.
34. Zou, J.G., Huang, Y.Z., Cao, K., Yang, G., Yin, H., Len, J., Hsieh, T.C., and Wu, J.M., Effect of resveratrol on intimal hyperplasia after endothelial denudation in an experimental rabbit model, Life Sci., 68, 153, 2000.
35. Kuo, PC. and Schroeder, R.A., The emerging multifaceted roles of nitric oxide, Ann. Surg, 221, 220, 1995.
36. Furchgott, R.F. and Zawadzki, J.V., The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, Nature, 288, 373, 1980.
37. Radomski, M.W., Palmer, R.M., and Moncada, S., Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium, Lancet, 2, 1057, 1987.
38. Radomski, M.W., Palmer, R.M., and Moncada, S., The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium, Biochem. Biophys. Res. Commun., 148, 1482, 1987.
39. Gauthier, T.W., Scalia, R., Murohara, T., Guo, J.P, and Lefer, A.M., Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia, Arterioscler. Thromb. Vasc. Biol., 15, 1652, 1995.
40. Zeiher, A.M., Fisslthaler, B., Schray-Utz B, and Busse, R., Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells, Circ. Res, 76, 980, 1995.
41. Sarkar, R., Meinberg, E.G., Stanley, J.C., Gordon, D., and Webb, R.C., Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells, Circ. Res., 78, 225, 1996.
42. Lloyd-Jones, D.M. and Bloch, K.D., The vascular biology of nitric oxide and its role in atherogenesis, Annu. Rev. Med., 47, 365, 1996.
43. Barakat, A.I. and Davies, P.F., Mechanisms of shear stress transmission and transduction in endothelial cells, Chest, 114, 58S, 1998.
44. Schaller, M.D. and Parsons, J.T., Focal adhesion kinase and associated proteins, Curr. Opin. Cell Biol., 6, 705, 1994.
45. Mattivi, F., Solid phase extraction of trans-resveratrol from wines for HPLC analysis, Z. Lebensm. Unters. Forsch., 196, 522, 1993.
46. Soleas, G.J., Diamandis, E.P, and Goldberg, D.M., Resveratrol: a molecule whose time has come? and gone?, Clinical Biochem., 30, 91, 1997.
47. Juan, M.E., Lamuela-Raventos, R.M., de la Torre-Boronat, M.C., Planas, J.M., Determination of trans-resveratrol in plasma by HPLC, Anal. Chem., 71, 747, 1999.
48. Bertelli, A., Bertelli, A.A., Gozzini, A., and Giovanni, L., Plasma and tissue resveratrol concentrations and pharmacological activity, Drugs Exp. Clin. Res., 24, 133, 1998.
49. Blache, D., Rustan, T., Durand, P, Lesgards, G., and Loreau, N., Gas chromatographic analysis of resveratrol in plasma, lipoproteins, and cells after in vitro incubations, J. Chromatogr. B. Biomed. Sci. Appl., 702, 103, 1997.
50. Piotrowicz, R.S., Weber, L.A., Hickey, E., and Levin, E.G., Accelerated growth and senescence of arterial endothelial cells expressing the small molecular weight heat-shock protein HSP27, FASEB J, 9, 1079, 1995.
51. Piotrowicz, R.S., Hickey, E., and Levin, E.G., Heat shock protein 27 kDa expression and phosphorylation regulates endothelial cell migration, FASEB J., 12, 1481, 1998.
52. Gray, C.C., Amrani, M., Smolenski, R.T., Taylor, G.L., and Yacoub, M.H., Age dependence of heat stress mediated cardioprotection, Ann. Thorac. Surg., 70, 621, 2000.
53. Bruey, J.M., Paul, C., Fromentin, A., Hilpert, S., Arrigo, A.P, Solary, E., Garrido, C., Differential regulation of HSP27 oligomerization in tumor cells grown in vitro and in vivo, Oncogene, 19, 4855, 2001.
54. Arrigo, A.P, Hsp27: novel regulator of intracellular redox state, 1UBMB Life, 52, 303, 2001.
55. Arrigo, A.P, Paul, C., Ducasse, C., Sauvageot, O., and Kretz-Remy, C., Small stress proteins: modulation of intracellular redox state and protection against oxidative stress, Prog. Mol. Subcell. Biol., 28, 171, 2002.
56. Kishi, H., Nakagawa, K., Matsumoto, M., Suga, M., Ando, M., Taya, Y., and Yamai-zumi, M., Osmotic shock induces G1 arrest through p53 phosphorylation at Ser33 by activated p38MAPK without phosphorylation at Ser15 and Ser20, J. Biol. Chem., 276, 39115, 2001.
57. Lavoie, J.N., L’Allemain, G., Brunet, A., Muller, R., and Pouyssegur, J., Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway, J. Biol. Chem., 271, 20608, 1996.
58. Casanovas, O., Miro, F., Estanyol, J.M., Itarte, E., Agell, N., and Bachs, O., Osmotic stress regulates the stability of cyclin D1 in a p38SAPK2-dependent manner, J. Biol. Chem., 275, 35091, 2000.
59. Kim, G.Y., Mercer, S.E., Ewton, D.Z., Yan, Z., Jin, K., and Friedman, E., The stress-activated protein kinases p38 alpha and JNK1 stabilize p21(Cip1) by phosphorylation, J. Biol. Chem, 277, 29792, 2002.
60. Li, S., Kim, M., Hu, Y.L., Jalali, S., Schlaepfer, D.D., Hunter, T., Chien, S., and Shyy, J.Y., Fluid shear stress activation of focal adhesion kinase. Linking to mitogen-activated protein kinases, J. Biol. Chem., 272, 30455, 1997.